Search Ontology:
ChEBI

alpha-L-Fucp-(1->3)-beta-D-Galp-(1->4)-beta-D-Glcp

Term ID
CHEBI:148092
Synonyms
  • (2S,3S,4R,5S,6S)-2-[(2R,3S,4S,5R,6S)-3,5-dihydroxy-2-(hydroxymethyl)-6-[(2R,3S,4R,5R,6R)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-4-yl]oxy-6-methyloxane-3,4,5-triol
  • 6-deoxy-alpha-L-galacto-hexopyranosyl-(1->3)-beta-D-galacto-hexopyranosyl-(1->4)-beta-D-gluco-hexopyranose
  • 6-deoxy-alpha-L-galactopyranosyl-(1->3)-beta-D-galactopyranosyl-(1->4)-beta-D-glucopyranose
  • alpha-L-fycopyranosyl-(1->3)-beta-D-galactopyranosyl-(1->4)-beta-D-glucopyranose
  • Fuc(a1-3)Gal(b1-4)b-Glc
Definition
A trisaccharide consisting that is beta-lactose in which the hydroxy group at the 3' position has been converted into the corresponding α-L-fucopyranosyl derivative.
References
  • glygen:G16348WN
  • glytoucan:G16348WN
Ontology
ChEBI  ( EBI )
Relationships
Phenotype
Phenotype resulting from alpha-L-Fucp-(1->3)-beta-D-Galp-(1->4)-beta-D-Glcp
Phenotype where environments contain alpha-L-Fucp-(1->3)-beta-D-Galp-(1->4)-beta-D-Glcp
Phenotype modified by environments containing alpha-L-Fucp-(1->3)-beta-D-Galp-(1->4)-beta-D-Glcp
Phenotype affecting alpha-L-Fucp-(1->3)-beta-D-Galp-(1->4)-beta-D-Glcp
Human Disease Model